Paloma Partners’s Astera Labs ALAB Stock Holding History

Paloma Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,999	Closed	-$1.08M	–	128
2025 Q2	$1.08M	Buy	+11,999	New	+$948K	0.16%	73
2024 Q4	–	Sell	-12,200	Closed	-$639K	–	1130
2024 Q3	$639K	Buy	+12,200	New	+$573K	0.02%	546

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Paloma Partners's ALAB Position: Q3 2025 in Review

Paloma Partners sold out of Astera Labs (ALAB) in Q3 2025, closing a stake of 11,999 shares — an estimated $1.08M sold.

Paloma Partners first reported a position in ALAB in Q3 2024 and held it in 2 quarters. The position peaked at $1.08M in Q2 2025. 660 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

Paloma Partners reported no remaining Astera Labs position as of Q3 2025 after selling out during the quarter.
Paloma Partners sold 11,999 Astera Labs shares in Q3 2025, an estimated $1.08M.
Paloma Partners first reported a position in Astera Labs in Q3 2024 and held it in 2 quarters.
Paloma Partners's Astera Labs position peaked at $1.08M in Q2 2025.
660 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on Paloma Partners's 13F filing for Q3 2025, filed 14 Nov 2025.